Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells

INTRODUCTION: Mesenchymal stromal cells (MSCs) have opened a new window to treat inflammatory and non-inflammatory diseases. Nonetheless, their clinical applications require rigorous control and monitoring procedures to ensure full compliance with the principles of good manufacturing practice (GMP)....

Descripción completa

Detalles Bibliográficos
Autores principales: Tayebi, Behnoosh, Babaahmadi, Mahnaz, Pakzad, Mohammad, Hajinasrollah, Mostafa, Mostafaei, Farhad, Jahangiri, Shahrbanoo, Kamali, Amir, Baharvand, Hossein, Baghaban Eslaminejad, Mohamadreza, Hassani, Seyedeh-Nafiseh, Hajizadeh-Saffar, Ensiyeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137136/
https://www.ncbi.nlm.nih.gov/pubmed/35619148
http://dx.doi.org/10.1186/s13287-022-02899-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137136/
https://www.ncbi.nlm.nih.gov/pubmed/35619148
http://dx.doi.org/10.1186/s13287-022-02899-9

Ejemplares similares